Summary.-Two proprietary semi-permanent hair dyes were tested for carcinogenicity in A and DBAf mice by repeated topical applications in aqueous acetone. Mice of both strains developed lymphoid tumours but experimental differences were marked only in DBAf mice. A number of tumours of the ovary and uterus, and some skin papillomas near the penis, occurred in dye-treated but not in control DBAf mice. As many hair-dye constituents are known mutagens, adequate carcinogenicity testing of these substances, and epidemiological study of exposed human populations, are needed for evaluating possible health hazards from hair dyeing.
EXISTING methods for carcinogenicity testing of chemicals in animals are slow and expensive, -and quite impracticable for monitoring the large numbers of new and existing environmental chemicals. There is consequently great current interest in various short-term assays that, though not capable of proving the carcinogenicity of a compound, may be valuable as screening tests. Of the battery of tests considered necessary for adequate prescreening, at present the most useful appear to be those which detect chemically-induced reversion to prototropy in amino-acid-requiring mutants of Salmonella typhimurium and Escherichia coli. These test have been developed particularly by Ames and his colleagues, who have reported the results of testing some 300 carcinogenic and non-carcinogenic compounds (McCann et al., 1975; McCann and Ames, 1976) .
In June 1975, independent studies were reported by Ames, Kammen and Yamasaki and by Searle et al., which showed that a range of hair-dye formulations, marketed in the U.S.A. and U.K. respectively, had considerable activity as mutagens in these bacterial tests. Various aromatic-amine constituents of the dyes 31 were also found active. Shortly afterwards, MacPhee and Podger (1975) reported the mutagenicity of hair dyes sold in Australia. There has since been much discussion regarding the significance of these results, which brought to the fore questions concerning both the possible health hazards of exposure to these widely used dye chemicals, and the validity of the bacterial tests as indicators of carcinogenic activity.
The test carried out by Ames et al., (1975) derived from an observation made during a students' practical class. Those reported by Searle et al., (1976) were carried out as a result of animal tests of two proprietary hair dyes, to which our attention had been directed because of their use by a patient at the East Birmingham Hospital (Gyde, personal communication 1973) .
The patient, a 52-year-old married woman, presented in 1972 with anaemia and neutropenia. Routine questioning elicited that she had frequently used two "semi-permanent" (non-oxidizing) hair dyes over several years. The anaemia responded to iron but, as expected, she remained neutropenic. Because of a suspicion that the hair dyes might have been a cause of her condition, she was advised This communication reports the results of these experiments, during which there was a demonstration that the dyes were mutagenic in bacteria (Venitt and Searle, 1976; Searle, 1977) .
MATERIALS AND METHODS
Hair dyes. These were Rimmel hair colourant shampoos of two shades, "Golden Silk" and "Really Brown" (referred to as GS and RB), purchased from a large chain store. The active ingredients were 2-nitro-p-phenylenediamine (2NPPD; Colour Index 76070) and 4-nitro-o-phenylenediamine (4NOPD; C.I. 76021) in GS, and C.I. Acid Black 107 (an azo-dye-metal complex) and 4-amino-2-nitrophenol (C.I. 76555) in RB.
GS and RB are "semi-permanent" dyes, wNhich are used directly writhout addition of oxidant and are gradually removed from the hair during subsequent shampooings. They are dark viscous fluids, used in a similar manner to shampoos, but users are instructed to leave the second application on the hair for 10-15 min (GS) or 20 min (RB) for colouring to take place. The analysis.-The statistical significances of the observed differences between control and treated groups were determined using the "logrank test" (Peto et al., 1977) . A survival time in weeks was determined for each mouse and in the context, of the analysis, an "event" was recorded only if death was accompanied by the diagnosis of a tumour. Deaths from other causes were, however, accounted for in the figure for "extent of exposure".
Taking each mouse-strain as a group, controls were compared with treated mice for all tumours and separately for lymphomas.
Subsequently, comparisons in terms of strain, sex, and dye (8 tests in all) were made for "all tumours" alone, the numbers for lymphoma being too small to subdivide. To allow for the possible effect that sex might have on prognosis, the individual results for males and females were added to study the total effect.
RESULTS

Toxicity
The treatments were well tolerated by the A-strain mice and initially by the DBAf mice also. However, between 13 and 26 weeks of treatment some male DBAf mice became emaciated and were killed, and the volumes applied were therefore halved at 24 weeks in this strain only.
The toxic effects were centred on the urogenital tract, and may have been at least partly due to obstruction by crystals which were sometimes seen in the bladder and on the skin round the penis. The penile region was frequently distended and in 3 mice small squamous papillomas developed here. The bladder and seminal vesicles were sometimes very distended and, microscopically, dilation of renal tubules was seen. This evidence of toxicity was much less common in RB-treated mice, the times to 75% survival being 48 weeks (GS) and 64 weeks (RB). Of the DBAf controls, 78% survived to the end of the experiment at 80 weeks.
Many DBAf mice had noticeably distended stomachs at necropsy and histological examination showed chronic gastritis in 3 controls, 4 GS-treated and 9 RB-treated mice. Tumour incidence by strain Sixty-four tumours were observed in the treated and control mice, and times at which they were found are summarized in Table I . Tumours of the lymphoid system accounted for half of those observed, and are listed separately. An initial analysis of the results showed a marked difference in the pattern of tumour development between strains. Each strain has therefore been considered separately.
When tumours at all sites were analysed for Strain A mice (Table II) the observed number of 13 tumours in controls was not significantly different from that of 29 tumours in the two treated groups (X2 = 0 005; d.f. 1; P > 0.05), nor was there a significant excess of lymphomas in the treated groups (X2 0-005; d.f. -1;P > 0.05). Further subdivision by sex and treatment group showed equally close correspondence between observed numbers and "extent of exposure".
For tumours at all sites in DBAf mice the difference between observed numbers for controls (3) and the treated group (19) was statistically significant (X2 = 6*06; d.f. 1; P < 0-05). Although in this strain only one lymphoma was observed in controls and 8 in the treated groups, the numbers were too small for numerical assessment.
Tumour incidence by treatment
No statistically significant effect could be demonstrated in Strain A mice treated showing marked nuclear pleomorphism and frequent mitoses. Six dye-treated DBAf mice developed ovarian tumours. At 80 weeks mucinous cystadenomas of the ovary were found in 4 GS-treated mice, in one case in addition to a lymphoma. These tumours were lined by complex infolded papillary epithelium composed of tall columnar cells with clear cytoplasm (Fig. 4) . In the RB-treated mice an ovarian granulosa-cell tumour was found at 79 weeks and a cystadeno- carcinoma at 80 weeks. This tumour had metastasized to the inguinal region and presented with a large mass consisting of well defined acinar structures set in a fibrous stroma (Fig. 5 ). As is seen from Table I , the main findings were tumours of the lymphoid system, which occurred in treated and conitrol mice of both strains, and tumours of the reproductive tract, which were found in dye-treated DBAf females only.
In control A mice, the first lymphoid tumour was found at 61 weeks, while these occurred from 38 weeks in RBtreated animals and from 48 weeks with GS. The additional lymphoid tumours found on ending the experiment at 80 weeks, however, brought the final incidences to 25.000 and 21.900 in RB-treated and control animals respectively, and to 1466% with GS treatment. The proportion of lymphoid tumours in controls was rather higher than expected from previous experience with this strain, for example in an experiment in which mice of 4 strains were treated neonatally with lV-ethyl-lV-nitrosourea (Searle and Jones, 1976) when only one lymphoid tumour occurred in 15 control A mice examined post mortem.
In the DBAf mice the experimental differences were more marked, with lymphoid tumours present in 5/31 (12.2%) of GS-treated mice and 3/31 (9.70 of RBtreated mice, compared with 1/30 (3.30o) in controls, despite longer survival in the latter group. Again, these tumours occurred considerably earlier with dye treatment, from 26 weeks with GS and 41 weeks with RB. Perhaps of more significance, however, were the tumours of the female reproductive tract which occurred towards the end of the experiment in dyetreated DBAf mice only. Two fibrosarcomas of the uterus, one with secondary deposits in the liver, were found at 66 and 69 weeks in GS-treated mice, and at 79-80 weeks 4 GS mice and 2 RB mice had ovarian tumours. Based on females examined post mortem, there were uterine or ovarian tumours in 6/18 (33-3%) GS mice and 2/15 (13.3%) RB mice. Ovarian tumours in the 4 GS-treated mice were cystadenomas. In the RB group a classical mucinous cystadenocarcinoma of the ovary had metastasized to an inguinal lymph node, the other ovarian tumour being a granulosa-cell tumour.
Also of interest in the DBAf strain were the toxic effects on the male urinary system, which in three instances were accompanied by small squamous papillomas of the skin near the penis. The observations were almost entirely confined to the GS group, and it seems likely that they depended on one or both of the nitrophenylenediamines or their metabolic products, even though the diluted solutions as applied contained the very low levels of approximately 0-06%o (4NOPD) and 0.015% (2NPPD). Summarizing these observations, it appears that the treatments of the Strain A mice resulted mainly in a small acceleration of the appearance of "spontaneous" lymphoid tumours. In DBAf mice, however, there was both an earlier appearance and an increased incidence of tumours. The excess was due mainly to uterine, ovarian and skin tumours which were not seen in the control group. Although no statistically significant excess of lymphomas could be demonstrated because of small numbers, the occurrence of one lymphoma in controls and 8 in the treated mice enhanced the total effect, indicating that the treatments appeared to have been carcinogenic for DBAf mice.
However, the applications were made using relatively complex mixtures and, with the possible exception of the skin papillomas, the tumours cannot with confidence be attributed to particular dye The chief reason for suspecting that a number of hair dye constituents might be carcinogenic is their definite activity in a number of short-term screening tests, especially in the "Ames test" using bacterial mutants . Tests of some 300 carcinogens and non-carcinogens in the bacterial system showed a wide measure of qualitative agreement between mutagenic and carcinogenic activities (McCann et al., 1975;  McCann and Ames 1 976) while in an important comparative study of 6 shortterm tests for carcinogen detection (Purchase et al., 1976) tests for bacterial mutagenicity and for cell transformation in vitro showed the most consistent correlations with the presence or absence of carcinogenic activity.
However, only in the case of 2,4-diaminotoluene (m-toluylenediamine) has reasonably firm evidence of carcinogenicity been reported to date from animal tests. This dye, now no longer used in hair dyes in the U.S.A. (Burnett et al., 1975) was found to give rise to sarcomas on injection into rats (Umeda, 1955) and to liver carcinomas on feeding to rats (Ito et al., 1969) . It was recently claimed to be non-carcinogenic when applied to mouse skin (Giles, Chung and Kommineni, 1976) but this conclusion has been sharplv criticized by Bridges and Green (1976) however, considered that tests should be carried out using doses and conditions likely to yield maximum tumour incidence. This will often mean the use of dosages several orders of magnitude above the levels encountered by man. Weisburger (1976) has stressed the importance of establishing maximum tolerated doses at an early stage in carcinogenicity testing, and pointed out that even with the firmly established human carcinogen 2-naphthylamine high doses were necessary to reproduce the human condition in animals.
The view expressed by Burnett et al. (1975) of Burnett et al. (1975) and Kinkel and Holzmann (1973) , as well as in the experi-ments reported here, it may be impossible to decide which substance is responsible for any effect that is detected without further prolonged experimentation. It is, of course, because of the many difficulties involved in testing large numbers of environmental materials that there is such great current interest in the various short-term screening tests (Montesano, Bartsch and Tomatis, 1976; Purchase et al., 1976) .
A further and more direct approach to obtaining information on possible adverse effects of environmental materials becomes practicable when, as in the case of hair dyes, they have had widespread use for one or more decades. This is, of course, to conduct epidemiological studies directly on the exposed human populations. As persons engaged in dyeing in the hairdressing trade are exposed to considerably greater levels than are individual home dyers, these represent the population which it is probably most useful to study, and this in now being done in this country. National mortality trends for some major cancers are sometimes quoted (e.g. Corbett, 1976) as failing to provide evidence for a carcinogenic effect of hair dyes. Experience with important occupational carcinogens such as 2-naphthylamine suggests, however, that such data could only reasonably be expected to reveal a massive increase in a common cancer or the induction of a normally very rare one, and that valid epidemiological evidence is only likely to come from properly planned and conducted comparisons of exposed and non-exposed populations.
A number of aromatic amines used in hair dyes are well-known sensitizing agents (Hunter, 1975) and oxidizing (permanent) hair dyes are marketed with warnings that patch tests for sensitivity should be carried out before use. It has recently been suggested that some cases of aplastic anaemia may have resulted from hair-dye usage (Hamilton and Sheridan, 1976; Hans, 1976) though this view was contested by Jouhar (1976) . This is a further area in which proper epidemiological study is necessary before we can expect to have a comprehensive picture of the health aspects of the present very largescale usage of hair dyes.
